Overview of all newly launched venture capital funds in 2025

The Capvisory Fund Tracker scans dozens of sources each month, capturing newly announced funds that have successfully raised capital at least through their first closing. Here is the continuously updated overview for 2025.

list venture capital 2025

Capvisory Insights

Fund Tracker

Overview of all newly launched venture capital funds in 2025

Capvisory is an independent, founder-led advisory boutique specializing in fundraising, sell-side M&A, and buy-side M&A for fast-growing tech companies and their investors.

Founding Partner

Founding Partner

The Capvisory Fund Tracker scans dozens of sources each month, identifying newly announced funds that have successfully raised capital at least through their first closing. The goal is to provide founders with an up-to-date overview of funds that have recently secured fresh capital and are therefore actively deploying investments.

Tip for founders: If you’re currently seeking venture capital, prioritize VCs that have closed a fund in the last 1–2 years. These investors typically still have substantial “dry powder,” significantly increasing your chances of securing a deal.

The Capvisory Fund Tracker covers the USA, Canada, Europe, and the MENA region.

List of venture capital investors that successfully raised funds in 2025

January 2025
🇯🇵

$98M VC Fund: Focus on early-stage US and Japanese tech startups.

🇺🇸

$650M VC Fund: Sector-agnostic fund with a focus on Indian tech startups. Key investment areas include cybersecurity, SaaS, and AI-driven enterprise and consumer applications.

🇫🇮

$50M VC Fund: Invests in Finland and the Baltics, with historical ticket sizes of up to $1M.

🇺🇸

Funding undisclosed: Focus on B2B companies leveraging technology to address challenges in food and agriculture.

🇬🇧

$30M VC Fund: Focused on Early-Stage B2B SaaS and fintech.

🇺🇸

$425M VC Fund: Invests across all areas of medtech, with a focus on medical devices and data science.

🇧🇪

$255M VC Fund: Growth fund accelerating Europe’s B2B tech innovations.

🇧🇪

$52M first closing: Healthcare-focused VC fund investing in digital health and medtech across Europe, from seed to Series B.

🇺🇸

$500M VC Fund: Eli Lilly and Andreessen Horowitz partnership with focus on biotech and healthcare.

🇺🇸

$1.2M Angel Fund: Invests mainly in Connecticut-based startups (US).

🇺🇸

$255M VC Fund: Targets growth-stage companies in the healthcare sector in North America.

🇺🇸

$68M VC Fund: Early-stage fund focusing on sports and entertainment startups.

🇩🇪

$82M first closing: Early-stage fund specializing in B2B software investments.

🇺🇸

$12.5B VC Fund: Invests in leading software companies globally, supporting growth at any stage.

🇺🇸

$3.2B Expansion Fund: Invests in high-growth, mission-critical SMEs in Europe to create international champions.

🇨🇾

$26.6M first close: Sector-agnostic investor focused on Cypriot founders, investing between €100K and €1M, up to Series A.

🇪🇪

$100M VC Fund: Invests in defense startups developing military and dual-use technologies.

🇳🇱

$25M first close: Targets early-stage quantum technology startups globally, with a final fund target of €60M.

🇺🇸

$4.15M VC Fund: Focused on women’s health, including mental health, fertility, menopause, and aging.

🇦🇺

$30M VC Fund: Tennis Australia's venture arm, investing in sports, entertainment, media, and health startups at seed to Series A stage.

🇺🇸

$110M VC Fund: Invests mainly in AI, but also software, life sciences, and deep tech, from pre-seed to Series A.

🇮🇹

$60M first close: Climate tech and deep tech fund focusing on key transition industries such as energy, materials, industrials, and food.

🇺🇸

$770M VC Fund: Invests in tech companies in Greater Seattle, the Pacific Northwest, and Silicon Valley across all stages.

🇫🇷

$220M VC Fund: Specializes on Series A & B rounds in green mobility, with a focus on Europe and Southeast Asia.

🇺🇸

$55.75M VC Fund: Invests in pre-seed and seed-stage healthcare startups, with check sizes ranging from $1M to $2M.

🇮🇳

$23M VC Fund: Invests in early-stage fintech startups in India.

🇺🇸

$340M VC Fund: A seed-stage biotech VC and therapeutics accelerator.

🇺🇸

$160M VC Fund: Early-stage, sector-agnostic investor with a total fund target of $400M.

🇳🇱

$168M VC Fund: A biotech-focused planetary health fund investing in B2B solutions for food, agriculture, materials, and sustainability.

🇳🇱

$50M VC Fund: Backs inclusive and gender-diverse startups.

🇳🇿

$122M VC Fund: Invests in New Zealand’s most promising early-stage startups, backing founders launching global companies.

🇵🇹

$2M first closing: A pan-European VC investing in pre-seed B2B blockchain startups, with a final fund target of $10M.

🇪🇬

$25M VC Fund: Supports startups in Egypt and Africa, helping them scale from ideation to regional and global expansion.

🇨🇦

$51M VC Fund: Focuses on pre-seed to Series A startups using technology to transform food and agriculture.

February 2025

To be published on March 3, 2025

Questions about the Fund Tracker?

We run the Fund Tracker to provide founders, investors, advisors, and all other stakeholders in the startup ecosystem with ongoing updates on the fundraising landscape. Have input for us, want to add a fund, or interested in the data behind the list? Feel free to reach out at hi@capvisory.de.

Capvisory is an independent, founder-led advisory boutique specializing in fundraising, sell-side M&A, and buy-side M&A for fast-growing tech companies and their investors.

Contact
Not interested in using a contactform?